Sleep disorders in Parkinson's disease: A narrative review of the literature

Reviews in the Neurosciences

Volumn 24, Issue 3, 2013, Pages 279-291

  Raggi, Alberto ^a   Bella, Rita ^b   Pennisi, Giovanni ^b   Neri, Walter ^a   Ferri, Raffaele ^c  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Neurodegeneration; Parkinson's disease; REM sleep behavior disorder; Sleep disorders; State dissociation

Indexed keywords

AMANTADINE; CLONAZEPAM; DOPAMINE TRANSPORTER; GABAPENTIN; LEVODOPA; MELATONIN; MODAFINIL; OREXIN; SELEGILINE;

ACTING OUT; AROUSAL; ARTICLE; BASAL GANGLION; BODY MASS; BREATHING DISORDER; CELL LOSS; CHOLINERGIC NERVE CELL; CLINICAL FEATURE; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE DURATION; DOPAMINERGIC NERVE CELL; DRUG INDUCED DISEASE; EPWORTH SLEEPINESS SCALE; FUNCTIONAL NEUROIMAGING; HUMAN; HYPNAGOGIC HALLUCINATION; LEWY BODY; MEYNERT BASAL NUCLEUS; MOTOR SYSTEM; MUSCLE ATONIA; NARCOLEPSY; NIGHTMARE; NOCTURIA; NONREM SLEEP; ORTHOSTATIC HYPOTENSION; PAINFUL ERECTION; PARASOMNIA; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PENIS ERECTION; PERIAQUEDUCTAL GRAY MATTER; PERIODIC LIMB MOVEMENT DISORDER; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REM SLEEP; RESTLESS LEGS SYNDROME; RISK BENEFIT ANALYSIS; SEROTONINERGIC NERVE CELL; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SUBTHALAMIC NUCLEUS; URINARY DYSFUNCTION; VISUAL HALLUCINATION; VIVID DREAM; WAKEFULNESS; ANIMAL; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; PARKINSON DISEASE; SLEEP; SLEEP DISORDERS; SLEEP, REM; WAKEFULNESS;

EID: 84886733793     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2013-0002     Document Type: Article

References (139)

1. Aldrich, M.S. (1990). Narcolepsy. N. Engl. J. Med. 323, 389-394.
2. Aldrich, M. (2000). Parkinsonism. In: Principles and practice of sleep medicine, M.H. Kryger, T. Roth and W.C. Dement, eds. (Philadelphia: Saunders), p. 1054.
3. American Academy of Sleep Medicine (2005). The International Classification of Sleep Disorders, 2 nd edition. Diagnostic and coding manual. (Weschester, IL: American Academy of Sleep Medicine).
4. April, R.S. (1966). Observations on Parkinsonian tremor in all-night sleep. Neurology 16, 720-724.
5. Arnulf, I. (2005). Excessive daytime sleepiness in parkinsonism. Sleep Med. Rev. 9, 185-200.
6. Arnulf, I., Bonnet, A.M., Damier, P., Bejjani, B.P., Seilhean, D., Derenne, J.P., and Agid, Y. (2000). Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 55, 281-288.
7. Arnulf, I., Konofal, E., Merino-Andreu, M., Houeto, J.L., Mesnage, V., Welter, M.L., Lacomblez, L., Golmard, J.L., Derenne, J.P., and Agid, Y. (2002). Parkinson's disease and sleepiness: an integral part of PD. Neurology 58, 1019-1024.
8. Aurora, R.N., Kristo, D.A., Bista, S.R., Rowley, J.A., Zak, R.S., Casey, K.R., Lamm, C.I., Tracy, S.L., and Rosenberg, R.S. (2012). The treatment of restless legs syndrome and periodic limb movement disorder in adults - an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 35, 1039-1062.
9. Banno, K. and Kryger, M.H. (2007). Sleep apnea: clinical investigations in humans. Sleep Med. 8, 400-426.
10. Blackett, H., Walker, R., and Wood, B. (2009). Urinary dysfunction in Parkinson's disease: a review. Parkinsonism Relat. Disord. 15, 81-87.
11. Boeve, B.F. (2010). REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorderneurodegenerative disease association, evolving concepts, controversies, and future directions. Ann. N. Y. Acad. Sci. 1184, 15-54.
12. Boeve, B.F., Silber, M.H., and Ferman, T.J. (2003). Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 4, 281-284.
13. Boeve, B.F., Silber, M.H., Saper, C.B., Ferman, T.J., Dickson, D.W., Parisi, J.E., Benarroch, E.E., Ahlskog, J.E., Smith, G.E., Caselli, R.C., et al. (2007). Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130, 2770-2788.
14. Boivin, D.B. and Montplaisir, J. (1991). The effects of L-dopa on excessive daytime sleepiness in narcolepsy. Neurology 41, 1267-1269.
15. Bonnet, A.M., Pichon, J., Vidailhet, M., Gouider-Khouja, N., Robain, G., Perrigot, M., and Agid, Y. (1997). Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Mov. Disord. 12, 509- 513.
16. Braak, H., Del, T.K., Rub, U., de Vos, R.A., Jansen Steur, E.N., and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
17. Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H., and Del, T.K. (2004). Stages in the development of Parkinson's diseaserelated pathology. Cell Tissue Res. 318, 121-134.
18. Brodsky, M.A., Godbold, J., Roth, T., and Olanow, C.W. (2003). Sleepiness in Parkinson's disease: a controlled study. Mov. Disord. 18, 668-672.
19. Brown, E., Brown, G.M., Kofman, O., and Quarrington, B. (1978). Sexual function and affect in parkinsonian men treated with L-dopa. Am. J. Psychiatry 135, 1552-1555.
20. Brusa, L., Petta, F., Pisani, A., Moschella, V., Iani, C., Stanzione, P., Miano, R., and Finazzi-Agrò, E. (2007). Acute vs chronic effects of L-dopa on bladder function in patients with mild Parkinson disease. Neurology 68, 1455-1459.
21. Campos-Sousa, R.N., Quagliato, E., da Silva, B.B., de Carvalho, R.M. Jr, Ribeiro, S.C., and de Carvalho, D.F. (2003). Urinary symptoms in Parkinson's disease: prevalence and associated factors. Arq. Neuropsiquiatr. 61, 359-363.
22. Carskadon, M.A., Dement, W.C., Mitler, M.M., Roth, T., Westbrook, P.R., and Keenan, S. (1986). Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9, 519-524.
23. Charcot, J.M. (1877). Lectures on Diseases of the Nervous System. Vol. 1 (London: The New Sydenham Society), p. 137.
24. Chokroverty, S. (2000). Diagnosis and treatment of sleep disorders caused by co-morbid disease. Neurology 54 (5 Suppl. 1), S8-S15.
25. Chotinaiwattarakul, W., Dayalu, P., Chervin, R.D., and Albin, R.L. (2011). Risk of sleep-disordered breathing in Parkinson's disease. Sleep Breath. 15, 471-478.
26. Cochen De Cock, V., Abouda, M., Leu, S., Oudiette, D., Roze, E., Vidailhet, M., Similowski, T., and Arnulf, I. (2010). Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med. 11, 247-252.
27. Crosby, N., Deane, K.H., and Clarke, C.E. (2003). Amantadine in Parkinson's disease. Cochrane Database Syst. Rev. 1, CD003468.
28. Diederich, N.J., Vaillant, M., Leischen, M., Mancuso, G., Golinval, S., Nati, R., and Schlesser, M. (2005a). Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov. Disord. 20, 1413-1418.
29. Diederich, N.J., Vaillant, M., Mancuso, G., Lyen, P., and Tiete, J. (2005b). Progressive sleep'destructuring'in Parkinson's disease. A polysomnographic study in 46 patients. Sleep Med. 6, 313-318.
30. Eisensehr, I., Wetter, T.C., Linke, R., Noachtar, S., von Lindeiner, H., Gildehaus, F.J., Trenkwalder, C., and Tatsch, K. (2001). Normal IPT and IBZM SPECT in drug-naive and L-Dopa-treated idiopathic restless legs syndrome. Neurology 57, 1307-1309.
31. Factor, S.A., McAlarney, T., Sanchez-Ramos, J.R., and Weiner, W.J. (1990). Sleep disorders and sleep effect in Parkinson's disease. Mov. Disord. 5, 280-285.
32. Ferini-Strambi, L. (2009). Treatment options for restless legs syndrome. Expert. Opin. Pharmacother. 10, 545-554.
33. Ferini-Strambi, L. and Zucconi, M. (2000). REM sleep behavior disorder. Clin. Neurophysiol. 111 (Suppl. 2), S136-140.
34. Ferri, R., Fulda, S., Cosentino, F.I.I., Pizza, F., and Plazzi, G. (2012). REM sleep behavior disorder or Parkinson's disease: the importance of occurring first. Sleep 35 (Suppl. 1), A250.
35. Finazzi-Agrò, E., Peppe, A., D'Amico, A., Petta, F., Mazzone, P., Stanzione, P., Micali, F., and Caltagirone, C. (2003). Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. J. Urol. 169, 1388-1391.
36. Fowler, C.J. (2007). Update on the neurology of Parkinson's disease. Neurourol. Urodyn. 26, 103-109.
37. Friedlander, W.J. (1952). Alterations of basal ganglion tremor during sleep. Neurology 2, 222-225.
38. Friedman, A. (1980). Sleep pattern in Parkinson's disease. Acta Med. Pol. 21, 193-199.
39. Fronczek, R., Overeem, S., Lee, S.Y., Hegeman, I.M., van Pelt, J., van Duinen, S.G., Lammers, G.J., and Swaab, D.F. (2008). Hypocretin (orexin) loss and sleep disturbances in Parkinson's disease. Brain 131 (Pt 1), e88.
40. Frucht, S., Rogers, J.D., Greene, P.E, Gordon, M.F., and Fahn, S. (1999). Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52, 1908-1910.
41. Frucht, S.J., Greene, P.E., and Fahn, S. (2000). Sleep episodes in Parkinson's disease: a wake-up call. Mov. Disord. 15, 601-603.
42. Fuller, P.M., Saper, C.B., and Lu, J. (2007). The pontine REM switch: past and present. J. Physiol. 584, 735-741.
43. Gagnon, J.F., Bédard, M.A., Fantini, M.L., Petit, D., Panisset, M., Rompré, S., Carrier, J., and Montplaisir, J. (2002). REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 59, 585-589.
44. Garcia-Borreguero, D., Larrosa, O., and Bravo, M. (2003). Parkinson's disease and sleep. Sleep Med. Rev. 7, 115-129.
45. Garcia-Borreguero, D., Egatz, R., Winkelmann, J., and Berger, K. (2006). Epidemiology of restless legs syndrome: the current status. Sleep Med. Rev. 10, 153-167.
46. Ghorayeb, I., Yekhlef, F., Chrysostome, V., Balestre, E., Bioulac, B., and Tison, F. (2002). Sleep disorders and their determinants in multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 72, 798-800.
47. Ghorayeb, I., Loundou, A., Auquier, P., Dauvilliers, Y., Bioulac, B., and Tison, F. (2007). A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov. Disord. 22, 1567-1572.
48. Gilbert, J.C., Willer, J.C., Bernheim-Chaltelain, C., Ecoffet, M., and Jaillon, P. (1976). Letter: Narcolepsy: REM sleep suppression by L-dopa. N. Engl. J. Med. 294, 849.
49. Gillin, J.C. and Wyatt, R.J. (1975). Schizophrenia: perchance a dream? Int. Rev. Neurobiol. 17, 297-342.
50. Godau, J., Schweitzer, K.J., Liepelt, I., Gerloff, C., and Berg, D. (2007). Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov. Disord. 22, 187-192.
51. Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S., Martinez-Martin, P., Poewe, W., Sampaio, C., Stern, M.B., Dodel, R., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129-2170.
52. Gray, R., Stern, G., and Malone-Lee, J. (1995). Lower urinary tract dysfunction in Parkinson's disease: changes relate to age and not disease. Age Ageing 24, 499-504.
53. Gregory, P., Morgan, K., and Lynall, A. (2012). Improving sleep management in people with Parkinson's. Br. J. Commun. Nurs. 17, 14-18.
54. Hashimoto, K., Oyama, T., Sugiyama, T., Park, Y.C., and Kurita, T. (2003). Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D1 and D2 receptors in rats. J. Pharmacol. Sci. 92, 143-148.
55. Hilker, R., Burghaus, L., Razai, N., Jacobs, A.H., Szelies, B., and Heiss, W.D. (2006). Functional brain imaging in combined motor and sleep disorders. J. Neurol. Sci. 248, 223-226.
56. Hoehn, M. and Yahr, M. (1967).Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
57. Högl, B. (2010). Sleep apnea in Parkinson's disease: when is it significant? Sleep Med. 11, 233-235.
58. Houeto, J.L. and Arnulf, I. (2002). Psychic disorders and somnolence. Rev. Neurol. 158 Spec. no 1, S102-S107.
59. Iranzo, A., Santamaría, J., Rye, D.B., Valldeoriola, F., Martí, M.J., Muñoz, E., Vilaseca, I., and Tolosa, E. (2005). Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 65, 247-252.
60. Iranzo, A., Molinuevo, J.L., Santamaría, J., Serradell, M., Martí, M.J., Valldeoriola, F., and Tolosa, E. (2006). Rapid-eyemovement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 5, 572-577.
61. Jellinger, K.A. (2012). Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov. Disord. 27, 8-30.
62. Johns, M.W. (1991). A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14, 540-545.
63. Karlsen, K., Larsen, J.P., Tandberg, E., and Jørgensen, K. (1999). Fatigue in patients with Parkinson's disease. Mov. Disord. 14, 237-241.
64. Kato, B., Yamada, K., Horiuchi, M., Hirayama, T., and Hasegawa, Y. (2007). Case of Parkinson's disease presenting with unique dyspneic attacks caused by oromandibular dystonia and sleep apnea syndrome. Rinsho Shinkeigaku. 47, 577-580.
65. Koller, W.C., Vetere-Overfield, B., Williamson, A., Busenbark, K., Nash, J., and Parrish, D. (1990). Sexual dysfunction in Parkinson's disease. Clin. Neuropharmacol. 13, 461-463.
66. Kumar, K.R., Lohmann, K., and Klein, C. (2012). Genetics of Parkinson disease and other movement disorders. Curr. Opin. Neurol. 25, 466-474.
67. Kuna, S.T. and Remmers, J.E. (1985). Neural and anatomic factors related to upper airway occlusion during sleep. Med. Clin. North Am. 69, 1221-1242.
68. Kunz, D. and Bes, F. (1999). Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov. Disord. 14, 507-511.
69. Lang, A.E. and Johnson, K. (1987). Akathisia in idiopathic Parkinson's disease. Neurology 37, 477-481.
70. Larsen, J.P. and Tandberg, E. (2001). Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs 15, 267-275.
71. Lees, A.J., Blackburn, N.A., and Campbell, V.L. (1988). The nighttime problems of Parkinson's disease. Clin. Neuropharmacol. 11, 512-519.
72. Louden, M.B., Morehead, M.A., and Schmidt, H.S. (1995). Activation by selegiline (Eldepryle) of REM sleep behavior disorder in Parkinsonism. W. V. Med. J. 91, 101.
73. Lu, J., Bjorkum, A.A., Xu, M., Gaus, S.E., Shiromani, P.J., and Saper, C.B. (2002). Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J. Neurosci. 22, 4568-4576.
74. Lu, J., Sherman, D., Devor, M., and Saper, C.B. (2006). A putative flip-flop switch for control of REM sleep. Nature 441, 589-594.
75. Mahowald, M.W. and Ettinger, M.G. (1990). Things that go bump in the night: the parasomnias revisited. J. Clin. Neurophysiol. 7, 119-143.
76. Mahowald, M.W. and Schenck, C.H. (1991). Status dissociates - a perspective on states of being. Sleep 14, 69-79.
77. Mahowald, M.W. and Schenck, C.H. (1992). Dissociated states of wakefulness and sleep. Neurology 42 (7 Suppl. 6), 44-51.
78. Mahowald, M.W. and Schenck, C.H. (1995). Complex motor behavior arising during the sleep period: forensic science implications. Sleep 18, 724-727.
79. Mahowald, M.W. and Schenck, C.H. (2001). Evolving concepts of human state dissociation. Arch. Ital. Biol. 139, 269-300.
80. Mahowald, M.W. and Schenck, C.H. (2005). Insights from studying human sleep disorders. Nature 437, 1279-1285.
81. Mahowald, M.W., Schenk, C.H., and Cramer Bornemann, M.A. (2011). Violent parasomnias forensic implications. Handb. Clin. Neurol. 99, 1149-1159.
82. Manni, R., Terzaghi, M., Sartori, I., Mancini, F., and Pacchetti, C. (2004). Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Med. 5, 189-193.
83. Maria, B., Sophia, S., Michalis, M., Charalampos, L., Andreas, P., John, M.E., and Nikolaos, S.M. (2003). Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir. Med. 97, 1151-1157.
84. McCarter, S.J., St Louis, E.K., and Boeve, B.F. (2012). REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease. Curr. Neurol. Neurosci. Rep. 12, 182-192.
85. McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O'Brien, J.T., Feldman, H, Cummings, J., Duda, J.E., Lippa, C., Perry, E.K., et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863-1872.
86. Mignot, E. (2001). A hundred years of narcolepsy research. Arch. Ital. Biol. 139, 207-220.
87. Mitler, M.M., Gujavarty, K.S., and Browman, C.P. (1982). Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electroenceph. Clin. Neurophysiol. 53, 658- 661.
88. Möller, J.C., Unger, M., Stiasny-Kolster, K., Kaussner, Y., Penzel, T., Oertel, W.H., and Hemmeter, U. (2009). Continuous sleep EEG monitoring in PD patients with and without sleep attacks. Parkinsonism Relat. Disord. 15, 238-241.
89. Möller, J.C., Unger, M., Stiasny-Kolster, K., and Oertel, W.H. (2010). Restless Legs Syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities? J. Neurol. Sci. 289, 135-137.
90. Nakazawa, Y., Tachibana, H., Kotorii, M., and Ogata, M. (1973). Effects of L-dopa on natural night sleep and on rebound of REM sleep. Folia Psychiatr. Neurol. Jpn. 27, 223-230.
91. Nausieda, P.A., Weiner, W.J., Kaplan, L.R., Weber, S., and Klawans, H.L. (1982). Sleep disruption in the course of chronic L-Dopa therapy: an early feature of the L-Dopa psychosis. Clin. Neuropharmacol. 5, 183- 194.
92. Ondo, W.G., Vuong, K.D., and Jankovic, J. (2002). Exploring the relationship between Parkinson disease and restless legs syndrome. Arch. Neurol. 59, 421-424.
93. Pacchetti, C., Martignoni, E., Terzaghi, M., Zangaglia, R., Mancini, F., Nappi, G., and Manni, R. (2003). Sleep attacks in Parkinson's disease: a clinical and polysomnographic study. Neurol. Sci. 24, 195-196.
94. Parkinson, J. (1817). An Essay on the Shaking Palsy (London: Sherwood, Neely and Jones).
95. Postuma, R.B., Gagnon, J.F., Vendette, M., and Montplaisir, J.Y. (2009). Idiopathic REM sleep behavior disorder in the transition to degenerative disease. Mov. Disord. 24, 2225-2232.
96. Perez-Lloret, S., Rey, M.V., Ratti, L., and Rascol, O. (2011). Pramipexole for the treatment of early Parkinson's disease. Expert. Rev. Neurother. 11, 925-935.
97. Perogamvros, L., Leemann, B., Perrig, S., and Schnider, A. (2013). Sleep paralysis in Parkinson's disease. Parkinsonism Relat. Disord. 19, 273-274.
98. Pittock, S.J., Parrett, T., Adler, C.H., Parisi, J.E., Dickson, D.W., and Ahlskog, J.E. (2004). Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov. Disord. 19, 695-699.
99. Plazzi, G., Corsini, R., Provini, F., Pierangeli, G., Martinelli, P., Montagna, P., Lugaresi, E., and Cortelli, P. (1997). REM sleep behavior disorders in multiple system atrophy. Neurology 48, 1094-1097.
100. Postuma, R.B. and Montplaisir, J. (2009). Predicting Parkinson's disease - why, when, and how? Parkinsonism Relat. Disord. 15 (Suppl. 3), S105-S109.
101. Postuma, R.B., Gagnon, J.F., and Montplaisir, J. (2010). Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J. Neurol. Neurosurg. Psychiatry 81, 1008-1013.
102. Postuma, R.B., Bertrand, J.A., Montplaisir, J., Desjardins, C., Vendette, M., Rios Romenets, S., Panisset, M., and Gagnon, J.F. (2012). Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov. Disord. 27, 720-726.
103. Raggi, A. and Ferri, R. (2010). Sleep disorders in neurodegenerative diseases. Eur. J. Neurol. 17, 1326-1338.
104. Raggi, A. and Ferri, R. (2012). Dissociated States of Being and Agrypnia Excitata. Encyclopedia of Sleep and Dreams: The Evolution, Function, Nature, and Mysteries of Slumber. Barrett, D. and McNamara, P., eds. (Santa Barbara, CA: Greenwood Publishers), pp. 211-213.
105. Raggi, A., Cosentino, F.I.I., Lanuzza, B., and Ferri, R. (2009). Behavioural and neurophysiologic features of state dissociation: a brief review of the literature and three descriptive case studies. Behav. Neurol. 22, 91-99.
106. Ray Chaudhuri, K., Martinez-Martin, P., Rolfe, K.A., Cooper, J., Rockett, C.B., Giorgi, L., and Ondo, W.G. (2012). Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease. Eur. J. Neurol. 19, 105-113.
107. Robertson, L.T. and Hammerstad, J.P. (1996). Jaw movement dysfunction related to Parkinson's disease and partially modified by L-Dopa. J. Neurol. Neurosurg. Psychiatry 60, 41-50.
108. Roth, T., Rye, D.B., Borchert, L.D., Bartlett, C., Bliwise, D.L., Cantor, C., Gorell, J.M., Hubble, J.P., Musch, B., Olanow, C.W., et al. (2003). Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med. 4, 275-280.
109. Rye, D.B. (2006). Excessive daytime sleepiness and unintended sleep in Parkinson's disease. Curr. Neurol. Neurosci. Rep. 6, 169- 176.
110. Rye, D.B., Bliwise, D.L., Dihenia, B., and Gurecki, P. (2000). FAST TRACK: daytime sleepiness in Parkinson's disease. J. Sleep. Res. 9, 63-69.
111. Sanchez-Ramos, J.R., Ortoll, R., and Paulson, G.W. (1996). Visual hallucinations associated with Parkinson disease. Arch. Neurol. 53, 1265-1268.
112. Schäfer, D. (2001). Schlafbezogene atmungsstorungen bei Parkinsonsyndromen: haufigkeit, art und behandlungsansatze. Somnologie 5, 103-114.
113. Schäfer, D. and Greulich, W. (2000). Effects of Parkinsonian medication on sleep. J. Neurol. 247 (Suppl. 4), IV/24-27.
114. Schenck, C.H. and Mahowald, M.W. (2005). Rapid eye movement sleep parasomnias. Neurol. Clin. 23, 1107-1126.
115. Schenck, C.H., Bundlie, S.R., Ettinger, M.G., and Mahowald, M.W. (1986). Chronic behavioural disorders of human REM sleep: a new category of parasomnias. Sleep 9, 293-308.
116. Schenck, C.H., Arnulf, I., and Mahowald, M.W. (2007). Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. Sleep 30, 683-702.
117. Schenck, C.H., Lee, S.A., Bornemann, M.A., and Mahowald, M.W. (2009). Potentially lethal behaviors associated with rapid eye movement sleep behavior disorder: review of the literature and forensic implications. J. Forensic Sci. 54, 1475-1484.
118. Schmidauer, C., Sojer, M., Seppi, K., Stockner, H., Högl, B., Biedermann, B., Brandauer, E., Peralta, C.M., Wenning, G.K., and Poewe, W. (2005). Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann. Neurol. 58, 630-634.
119. Schneider, J.S., Diamond, S.G., and Markham, C.H. (1986). Deficits in orofacial sensorimotor function in Parkinson's disease. Ann. Neurol. 19, 275-282.
120. Shapiro, B. and Spitz, H. (1976). Problems in the differential diagnosis of narcolepsy versus schizophrenia. Am. J. Psychiatry 133, 1321-1323.
121. Sharf, B., Moskovitz, C., Lupton, M.D., and Klawans, H.L. (1978). Dream phenomena induced by chronic L-Dopa therapy. J. Neural. Transm. 43, 143-151.
122. Siclari, F., Khatami, R., Urbaniok, F., Nobili, L., Mahowald, M.W., Schenck, C.H., Cramer Bornemann, M.A., and Bassetti, C.L. (2010). Violence in sleep. Brain 133, 3494-509.
123. Simuni, T. and Sethi, K. Nonmotor manifestations of Parkinson's disease (2008). Ann. Neurol. 64 (Suppl. 2), S65-S80.
124. Sinforiani, E., Pacchetti, C., Zangaglia, R., Pasotti, C., Manni, R., and Nappi, G. (2008). REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow-up. Mov. Disord. 23, 1441-1145.
125. Stern, M., Roffwarg, H., and Duvoisin, R. (1968). The Parkinsonian tremor in sleep. J. Nerv. Ment. Dis. 147, 202-210.
126. Tachibana, N., Kimura, K., Kitajima, K., Shinde, A., Kimura, J., and Shibasaki, H. (1997). REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. J. Neurol. Neurosurg. Psychiatry 63, 678-681.
127. Tandberg, E., Larsen, J.P., and Karlsen, K. (1999). Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov. Disord. 14, 922-927.
128. Thannickal, T.C., Lai, Y.Y., and Siegel, J.M. (2007). Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130, 1586-1595.
129. Thannickal, T.C., Lai, Y.Y., and Siegel, J.M. (2008). Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease. Brain 131 (Pt 1), e87.
130. Tracik, F. and Ebersbach, G. (2001). Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. Mov. Disord. 16, 500-506.
131. van Hilten, B., Hoff, J.I., Middelkoop, H.A., van der Velde, E.A., Kerkhof, G.A., Wauquier, A., Kamphuisen, H.A., and Roos, R.A. (1994). Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch. Neurol. 51, 922-928.
132. Vijayan, V.K. (2012). Morbidities associated with obstructive sleep apnea. Expert. Rev. Respir. Med. 6, 557-566.
133. Wenning, G.K., Ben Shlomo, Y., Magalhães, M., Daniel, S.E., and Quinn, N.P. (1994). Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117, 835-845.
134. Wetter, T.C. and Pollmächer, T. (1997). Restless legs and periodic leg movements in sleep syndromes. J. Neurol. 244 (4 Suppl. 1), S37-S45.
135. Wetter, T.C., Trenkwalder, C., Gershanik, O., and Högl, B. (2001). Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances. Wien Klin. Wochenschr. 113, 249-253.
136. Wienecke, M., Werth, E., Poryazova, R., Baumann-Vogel, H., Bassetti, C.L., Weller, M., Waldvogel, D., Storch, A., and Baumann, C.R. (2012). Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? J. Sleep Res. 21, 710-717.
137. Yeo, L., Singh, R., Gundeti, M., Barua, J.M., and Masood, J. (2012). Urinary tract dysfunction in Parkinson's disease: a review. Int. Urol. Nephrol. 44, 415-424.
138. Zahran, A.R., Simmerman, N., Carrier, S., and Vachon, P. (2001). Erectile dysfunction occurs following substantia nigra lesions in the rat. Int. J. Impot. Res. 13, 255-60.
139. Zesiewicz, T.A., Sullivan, K.L., and Hauser, R.A. (2006). Nonmotor symptoms of Parkinson's disease. Expert. Rev. Neurother. 6, 1811-1822.